Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, the top managed care news included a panel mostly endorsed the use of patient-reported outcomes for coverage of chimeric antigen receptor T-cell therapy; the US Preventive Services Task Force released new recommendations for cervical cancer screening; research found accountable care organization penetration may be changing how physicians work.
To listen, login to the website.
iTunes: http://apple.co/2eYWTss
TuneIn: http://bit.ly/2gv7iwj
Stitcher: http://bit.ly/2gCqtFg
Listen above or through one of these podcast services:
Many Questions to Ask in Setting National Coverage for CAR T Therapies
MEDCAC Panel Mostly Endorses PROs for CAR T Therapies
USPSTF Updates Cervical Cancer Screening Recommendations
ACO Penetration Linked to Decreased Work Hours, Less Self-Employment
Substituting Brand-Name Combinations for Generics Could Have Saved Medicare $925 Million in 2016
American Association of Diabetes Educators 2018
Evidence-Based Oncology—August 2018
Read more about the stories in this podcast:
World Pancreatic Cancer Day 2024: Looking Back at Progress in Cell and Gene Therapy
November 21st 2024In observance of World Pancreatic Cancer Day, held on the third Thursday of November each year, we took a look back at the past year's news in cell and gene therapy for pancreatic cancer indications.